We found several new targets for aspirin which are enriched in the pathways that are strongly involved in inflammatory, cardiovascular disease and cancer, such as vascular endothelial growth factor (VEGF), mitogen-activated protein kinase(MAPK), Fc epsilon RI signaling and arachidonic acid metabolism signaling pathways. Here, VEGFA is linked to cardiovascular disorder.